Urso Stefano, Sadaba Rafael, Aldamiz-Echevarria Gonzalo
Department of Cardiac Surgery, Clinica Capio, Albacete, Spain.
Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):510-8. doi: 10.1510/icvts.2009.207597. Epub 2009 Jun 4.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is patient-prosthesis mismatch an independent risk factor for 30-day and mid-term overall mortality in adult patients undergoing aortic valve replacement (AVR)? Altogether, almost 400 papers were found using the reported search, of which 22 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. The majority of the selected articles have focused their analysis on moderate mismatch defined mostly by the presence of an indexed effective orifice area (IEOA)<or=0.85 cm(2)/m(2). In fact, because of the low incidence of patients with severe mismatch, these were often grouped for the statistical analysis with patients with moderate mismatch. Only six studies have analyzed the specific condition of severe mismatch (IEOA<0.65 cm(2)/m(2)). Three studies used the IEOA or indexed geometric orifice area (IGOA) as a continuous variable. We conclude that there is no strong evidence that moderate patient-prosthesis mismatch (PPM) (indexed IEOA<or=0.85 and >0.65 cm(2)/m(2)) is an independent risk factor for 30-day or mid-term overall mortality for adult patients undergoing AVR. An exception could be represented by patients with poor ejection fraction, a condition that can make moderate mismatch a predictor of overall mortality after AVR. On the other hand, severe mismatch is a predictor of overall 30-day or mid-term mortality for patients undergoing AVR independently from the presence of poor ejection fraction. In conclusion, our review suggests that the condition of severe PPM should be always avoided, while the presence of moderate mismatch could be tolerated in patients with normal ejection fraction without any impact on overall survival.
根据结构化方案撰写了一篇心脏外科的最佳证据主题。所探讨的问题是:在接受主动脉瓣置换术(AVR)的成年患者中,患者-人工瓣膜不匹配是否是30天及中期总体死亡率的独立危险因素?通过报告的检索共找到近400篇论文,其中22篇代表了回答该临床问题的最佳证据。将这些论文的作者、期刊、发表日期和国家、所研究的患者组、研究类型、相关结局和结果制成表格。大多数入选文章将分析重点放在主要由指数化有效瓣口面积(IEOA)≤0.85 cm²/m²定义的中度不匹配上。事实上,由于严重不匹配患者的发生率较低,这些患者在统计分析中常与中度不匹配患者归为一组。只有六项研究分析了严重不匹配(IEOA<0.65 cm²/m²)的具体情况。三项研究将IEOA或指数化几何瓣口面积(IGOA)用作连续变量。我们得出结论,没有充分证据表明中度患者-人工瓣膜不匹配(PPM)(指数化IEOA≤0.85且>0.65 cm²/m²)是接受AVR的成年患者30天或中期总体死亡率的独立危险因素。射血分数低的患者可能是个例外,这种情况可使中度不匹配成为AVR后总体死亡率的预测因素。另一方面,严重不匹配是接受AVR患者30天或中期总体死亡率的预测因素,与射血分数低无关。总之,我们的综述表明应始终避免严重PPM情况发生,而对于射血分数正常的患者,中度不匹配情况可以耐受,且对总体生存率无任何影响。